Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

Role of neutrophil extracellular traps in primary graft dysfunction after lung transplantation

FY 2019-20

Summary
"Neutrophils, which are the main immune cells in the blood, play a significant role in complications associated to human lung transplant. These cells can be stimulated by various factors in donors and in recipients prior and during transplant procedure. Recently, neutrophils were found to produce spider web-like structures in blood, termed neutrophil extracellular traps (NETs). These NETs are produced upon neutrophil overstimulation, as in lung transplant procedure. About 15% of lung recipients develop life-threatening complications due to dysregulated functions of their freshly grafted lungs, and we believe that NETs are responsible by blocking the blood flow in the graft vessels. In order to explore the role of NETs in postoperative complications following lung transplant, several blood samples are taken from the donor and recipient prior, during and after surgery in order to quantifiy NETs and other molecules that could induce neutrophil stimulation. That permits to follow the dynamics of NETs production and inflammation during the surgery and the recovery period. When possible, we also sample lung tissue to be grafted in order to screen for the presence of NETs.Our preliminary data (based on 20 lung recipients, including 4 deaths within 60 days post-procedure) are indicating that NETs play a major role in postoperative complications. The potential benefits of our research can be significant, considering that a treatment already exists to degrade NETs. This treatment (Pulmozyme) is used in cystic fibrosis patients and can readily be available for use in lung transplant patients. In short term, we may have a possible life-saving, secure and low-cost therapeutic approach to help a great number of recipients with severe complications following lung transplant."
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
428712
Name
Bonneau Steven
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Role of neutrophil extracellular traps in primary graft dysfunction after lung transplantation
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chronic Obstructive Pulmonary Disease; Cystic Fibrosis; Idiopathic Pulmonary Fibrosis; Inflammation; Lung Transplantation; Neutrophil Extracellular Traps; Neutrophils; Pulmonary Hypertension; Surgery
Abstract
"Neutrophils, which are the main immune cells in the blood, play a significant role in complications associated to human lung transplant. These cells can be stimulated by various factors in donors and in recipients prior and during transplant procedure. Recently, neutrophils were found to produce spider web-like structures in blood, termed neutrophil extracellular traps (NETs). These NETs are produced upon neutrophil overstimulation, as in lung transplant procedure. About 15% of lung recipients develop life-threatening complications due to dysregulated functions of their freshly grafted lungs, and we believe that NETs are responsible by blocking the blood flow in the graft vessels. In order to explore the role of NETs in postoperative complications following lung transplant, several blood samples are taken from the donor and recipient prior, during and after surgery in order to quantifiy NETs and other molecules that could induce neutrophil stimulation. That permits to follow the dynamics of NETs production and inflammation during the surgery and the recovery period. When possible, we also sample lung tissue to be grafted in order to screen for the presence of NETs.Our preliminary data (based on 20 lung recipients, including 4 deaths within 60 days post-procedure) are indicating that NETs play a major role in postoperative complications. The potential benefits of our research can be significant, considering that a treatment already exists to degrade NETs. This treatment (Pulmozyme) is used in cystic fibrosis patients and can readily be available for use in lung transplant patients. In short term, we may have a possible life-saving, secure and low-cost therapeutic approach to help a great number of recipients with severe complications following lung transplant."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bonneau, Steven
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~